✦ LIBER ✦

Long-term tamoxifen adjuvant therapy in node-positive breast cancer: A metabolic and pilot clinical study

✍ Scribed by Douglass C. Tormey; V. Craig Jordan

Publisher: Springer US
Year: 1984
Tongue: English
Weight: 588 KB
Volume: 4
Category: Article
ISSN: 0167-6806
DOI: 10.1007/bf01806042

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adjuvant tamoxifen for pre- and postmeno

Adjuvant tamoxifen for pre- and postmenopausal women with estrogen receptor positive, node positive breast cancer: A randomized study

✍ S. Gundersen; E. Hannisdal; J. A. Søreide; A. Skarstein; J. E. Varhaug 📂 Article 📅 1995 🏛 Springer US 🌐 English ⚖ 368 KB

Adjuvant chemo- and hormonal therapy in

Adjuvant chemo- and hormonal therapy in locally advanced breast cancer: a randomized clinical study

✍ Caro Schaake-Koning; Els Hamersma Van Der Linden; Guus Hart; Evert Engelsman 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 632 KB

Randomized trial to evaluate the additio

Randomized trial to evaluate the addition of tamoxifen to cyclophosphamide, 5-fluorouracil, prednisone adjuvant therapy in premenopausal women with node-positive breast cancer

✍ James N. Ingle; Lloyd K. Everson; H. Sam Wieand; Stephen A. Cullinan; Lester E. 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 787 KB

Prognostic significance of tumor grade i

Prognostic significance of tumor grade in clinical trials of adjuvant therapy for breast cancer with axillary lymph node metastasis

✍ Ben W. Davis; Richard D. Gelber; Aron Goldhirsch; William H. Hartmann; Gottfried 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 835 KB

Prognostic factors of early distant recu

Prognostic factors of early distant recurrence in hormone receptor-positive, postmenopausal breast cancer patients receiving adjuvant tamoxifen therapy : Results of a retrospective analysis

✍ Marc Debled; Gaëtan MacGrogan; Véronique Brouste; Simone Mathoulin-Pelissier; Mi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB 👁 1 views

## Abstract ## BACKGROUND Current adjuvant hormone therapy in postmenopausal women with breast cancer is debatable between upfront aromatase inhibitors (AIs) and sequential treatment with tamoxifen. A major concern is the higher rate of early recurrences observed with sequential treatment. The aut

Adjuvant six cycles of high-dose adriamy

Adjuvant six cycles of high-dose adriamycin, cyclophosphamide, methotrexate, 5-fluorouracil (ACMF) vs. 12 cycles of low-dose acmf with tamoxifen for premenopausal, node-positive breast cancer patients: Results of a prospective randomized study

✍ Dr. Takashi Fukutomi; Sadako Akashi; Takeshi Nanasawa; Hiroshi Yamamoto 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 398 KB

A prospective randomized study was conducted to compare the adjuvant efficacy of six cycles of high-dose ACMF (Adriamycin, ADM; cyclophosphamide, CPA; methotrexate, MTX; 5-fluorouracil, 5-FU) with that of 12 cycles of low-dose ACMF in premenopausal, node-positive breast cancer patients. The six-cycl